InsiderTrades

Form 4 for ELOX Eloxx Pharmaceuticals, Inc.

Accepted 2026-05-08 16:44:52 ET · period of report 2025-09-19 · accession 0001193125-26-214815 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-05-08 16:44 2026-01-24 ELOX Walts Alan Edmund Dir M - OptEx — +1,875 15.6K +14% —
D 2026-05-08 16:44 2025-09-19 ELOX Walts Alan Edmund Dir A - Grant $0.00 +395.7K 395.7K New $0
D 2026-05-08 16:44 2026-01-24 ELOX Walts Alan Edmund Dir M - OptEx $0.00 -1,875 1,875 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-01-24 M A 1,875 — 15,567 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
2 Derivative Stock Option (Right to Buy) 2025-09-19 A A 395,680 $0.00 395,680 D $0.15 · — to 2035-09-19 395,680 Common Stock (F2) The stock option vested as to 1/36 on October 31, 2025, with the remaining options vesting thereafter in equal consecutive monthly increments for 35 months, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.
3 Derivative Restricted Stock Units 2026-01-24 M D 1,875 $0.00 1,875 D — · — to — 1,875 Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. (F3) The RSUs vested as to 50% on the first anniversary of January 24, 2024, and the remaining amount vested in two equal annual installments thereafter. (F3) The RSUs vested as to 50% on the first anniversary of January 24, 2024, and the remaining amount vested in two equal annual installments thereafter.